Kelfred Holdings Limited Overview
Kelfred is a small-cap, Hong Kong-headquartered contract manufacturer of eyewear — spectacle frames and sunglasses — producing primarily on an ODM/OEM basis for international eyewear retailers, trading houses and licensed brand owners, with a minor own-brand line ("Miga"). Manufacturing is concentrated in two PRC bases (Shenzhen, from 2013; a self-owned Jiangxi base, from 2016), with a third base in Thailand slated to start production in H2 2026 to diversify away from China-origin tariff and cost exposure. Europe is the dominant end-market, with Italy and the UK together accounting for roughly 57% of H1 2026 deliveries. FY2025 revenue was HK$500.3m, but gross margins have compressed from ~16% in FY2022 to 10.5% in H1 2026, and the group has posted losses since FY2024. In mid-2026 the founding Kwok family fully exited its shareholding, leaving a fragmented new shareholder base and an open question over strategic direction and "diversification".
Company's own description (latest annual report)
In its FY2025 annual report, the company describes itself as an established eyewear manufacturer in the PRC and Hong Kong producing and selling a wide range of spectacle frames and sunglasses, mainly through ODM and OEM business models, and offering integrated customised services spanning product design and development, raw-material procurement, production, quality control, packaging and delivery. It additionally sells OBM products under the "Miga" brand. It emphasises over 30 years of industry experience and a customer network of international eyewear retailers, trading companies and licensed brand owners, with Europe as its largest market [AR2025]. The FY2025 report states the first major production base was set up in Shenzhen in 2013 and a second, self-owned base in Jiangxi in 2016, with a third base in Thailand expected to be set up in 2026 [AR2025]; the H1 2026 report updates this to production readiness expected in H2 2026 [IR2026].
Business model and revenue model
| Dimension | Characterisation | Evidence |
|---|---|---|
| Core model | Contract manufacturing (ODM/OEM) of eyewear under customers' brands | [AR2025] |
| Own-brand | OBM under "Miga" — immaterial; revenue not separately disclosed | [AR2025] |
| Revenue type | 100% product sales, recognised at a point in time on delivery | [IR2026] note 4 |
| Service/licensing revenue | None in revenue line; ancillary design, service, sample/mould fees booked in "other income" (HK$4.9m combined in H1 2026) | [IR2026] note 5 |
| Subscription | — | — |
| Operating segment | Single segment: design, manufacture and sale of eyewear | [IR2026] note 4 |
Value chain position
Kelfred sits in the upstream manufacturing tier of the eyewear value chain: it designs (ODM) or builds to specification (OEM), procures materials (suppliers mainly PRC-based [IR2026]), manufactures and ships to brand owners/distributors who own the consumer relationship. It does not operate retail, does not hold major licences, and captures a thin manufacturing margin — 11.9% gross margin in FY2025 and 10.5% in H1 2026 [AR2025], [IR2026]. A related party controlled by the CEO, DEM FACTORY SRL (Italy), assembles frames/sunglasses using Italian suppliers and buys a small amount of product from the group (HK$1.6m in H1 2026) [IR2026].
Customer types and concentration
| Customer (anonymised) | H1 2024 | H1 2025 | H1 2026 |
|---|---|---|---|
| Customer A revenue (HK$ m) | 44.0 | 74.4 | 68.4 |
| Customer A % of revenue (derived) | 22.3 | 30.7 | 31.1 |
| Customer B revenue (HK$ m) | 31.8 | 34.2 | 28.9 |
| Customer B % of revenue (derived) | 16.1 | 14.1 | 13.2 |
| Customer C revenue (HK$ m) | 22.9 | 33.8 | 11.2 |
| Customer C % of revenue (derived) | 11.6 | 14.0 | 5.1 |
| Top-3 % of revenue (derived) | 50.0 | 58.8 | 49.4 |
Customers are primarily international eyewear retailers, trading companies and licensed brand owners [AR2025]. Concentration is high:
Sources: [IR2025], [IR2026]. Customer C fell below the 10% threshold in H1 2026.
End-markets
Delivery destinations are overwhelmingly Europe (Italy, UK, Spain, Sweden) and Hong Kong (likely trading-house intermediated re-exports), with smaller US, PRC, Japan and Philippines volumes [IR2026]. The company has stated it sold to over 35 countries in recent years [IR2025].
Independent characterisation
Kelfred is a sub-scale, price-taking ODM/OEM supplier in a fragmented, China-centric frame-manufacturing industry. Its economics are driven by (i) order volume from a handful of European customers, (ii) average selling price pressure, (iii) RMB/HKD exchange rates (costs in RMB, sales largely in USD/EUR/HKD), and (iv) labour productivity. The group lacks proprietary brands, licences or technology that would provide pricing power. Its balance sheet is ungeared (net cash, lease-only debt at period-ends) but working capital is funded partly through receivables factoring and short-term secured RMB bank loans drawn and repaid within each year. The July 2026 ownership change makes the investment case increasingly about corporate control and potential re-purposing of the listed vehicle rather than eyewear fundamentals alone.
Strategy
Stated strategy themes (latest annual and interim reports, paraphrased)
From the FY2025 Chairman's Statement and MD&A and the H1 2026 MD&A [AR2025], [IR2026]:
-
Cost control — continue to strengthen cost-saving measures and streamline operations.
-
Order capture — win more orders by supplying quality products.
-
Capacity and design — raise competitiveness by enhancing production capacity and creating more innovative designs.
-
Geographic manufacturing diversification — establish the Thailand production base.
-
Supply-chain optimisation.
-
Sustainability — integrate sustainability principles into business practices (no quantified targets).
-
Business diversification — eyewear remains the core, while management keeps exploring opportunities to diversify income streams. The board reiterated this after the July 2026 change in substantial shareholder [ANN-29JUL26].
The Chairman characterised the stance for 2026 as prudent and cautious [AR2025].
Initiative register (last 24 months)
| Initiative | Announced | Status | Targets disclosed | Source |
|---|---|---|---|---|
| Thailand production base | Mar 2026 (FY2025 results) | Being set up; THB leases signed; 5 staff; production expected H2 2026 | None (capex, capacity not disclosed) | [AR2025], [IR2026] |
| Cost-saving programme | Ongoing since 2024 | PRC headcount down ~26% Dec 2024→Jun 2026; staff costs FY2025 HK$107.1m vs HK$129.3m FY2024 | No quantified target | [AR2025], [IR2026] |
| Marketing push (incl. own-brand) | 2025–26 | Advertising and promotion +HK$3.7m in FY2025; selling costs +41% in H1 2026 | — | [AR2025], [IR2026] |
| Design/services monetisation | 2025–26 | Design + service fees rising (see Section 5) | — | [IR2026] |
| Diversification | Ongoing | No transaction announced | — | [IR2026] |
Medium-term financial targets / guidance
None disclosed. The company provides only qualitative outlook: a challenging environment into H2 2026 and 2027 due to trade frictions and geopolitics [IR2026]. No investor day has been held (none identified).
Products & Services
Kelfred does not publish a SKU-level catalogue in its periodic filings; product-material mix, unit volumes, ASPs and named customer programmes are not publicly disclosed in the filings reviewed. The portfolio as disclosed is set out below.
Analyst note. The rising share of design and service fees (combined design + product services + samples/moulds HK$4.9m in H1 2026 vs HK$2.7m in H1 2025) suggests Kelfred is trying to monetise its ODM design capability separately as unit pricing weakens. It remains small relative to revenue (~2.2%).
Product Portfolio
| Product / service | Description | Target customer | Business model | Pricing model | Disclosed revenue | Source |
|---|---|---|---|---|---|---|
Optical spectacle frames | Prescription-ready frames manufactured to customer designs (OEM) or Kelfred designs (ODM) | International eyewear retailers, trading companies, licensed brand owners | ODM/OEM | Per-unit contract pricing; ASP declining in 2025–26 | Not split; within HK$219.6m H1 2026 eyewear sales | [IR2026] |
Sunglasses | Non-prescription sun eyewear under customer brands | Same | ODM/OEM | Per-unit contract pricing | Not split | [IR2026] |
"Miga" own-brand eyewear | Original brand manufacturing line | — | OBM | — | Not disclosed (immaterial) | [AR2025] |
Product design services | Design work charged to customers | ODM customers | Fee | Per-project fee | HK$2.14m (H1 2026); HK$1.69m (H1 2025); HK$0.12m (H1 2024) — in other income | [IR2026], [IR2025] |
Product services | Service fees (nature not detailed) | Customers | Fee | — | HK$2.33m (H1 2026); HK$0.82m (H1 2025) | [IR2026] |
Samples and moulds | Sample/mould making charged to customers | Customers | Fee | Per item | HK$0.45m (H1 2026); HK$0.21m (H1 2025) | [IR2026] |
Material re-charges | Materials charged on to customers | Customers | Pass-through | Cost-plus | HK$1.28m (H1 2026) | [IR2026] |
Scrap sales & rework | Sale of scrap and rework services | — | Ancillary | — | HK$0.11m (H1 2026) | [IR2026] |
“—” = not publicly disclosed.
Financial Narrative
Income statement
Sources: [AR2025] five-year summary; D&A from [SA]; EPS derived on 500m shares (FY2025 −3.02 cents confirmed in results coverage).
Margins and growth
Revenue CAGR (derived): FY2021–FY2025 ≈ 3.6% p.a.; FY2017–FY2025 ≈ 4.1% p.a.
Commentary. The defining trend is margin destruction rather than revenue decline. Revenue in FY2025 (HK$500.3m) was a record, yet gross margin was ~4.4 points below FY2022. Management attributes the FY2024 collapse (GM 9.8%) to lower ASPs and cost pressure, the FY2025 partial recovery to higher order volumes and cost-saving measures, and the H1 2026 relapse (GM 10.5%) to competitive ASP declines plus RMB appreciation [AR2025], [IR2026]. "Other income" has been a material swing factor: in FY2023 it contributed HK$24.1m — more than six times the operating profit — and its normalisation explains much of the FY2024 loss; in 2025–26 it has been depressed by FX losses (H1 2026 net FX loss HK$3.1m) [IR2026]. Admin costs have been held flat at ~HK$60–62m for five years, so the business has very limited operating leverage at current gross margins: break-even at the operating line would require gross margin around 15% on FY2025 revenue (derived).
Balance sheet
Sources: [AR2025], [IR2025], [IR2026]; FY2023 cash from opening balance in [IR2025] cash flow; FY2023 debt derived from 8.3% gearing [AR2024s]. Year-end debt consists of lease liabilities only; however, the group draws secured short-term RMB bank loans each July and January and repays them within the year (e.g., RMB5.0m and RMB18.95m drawn in July 2026), so intra-year debt is higher than year-end snapshots suggest [IR2026] note 19. Goodwill/intangibles: none shown in the condensed balance sheet [IR2026].
Latest interim balance sheet (30 Jun 2026): total assets HK$257.3m; net assets HK$141.7m; cash HK$29.9m; lease liabilities HK$7.6m; inventories HK$68.3m; trade receivables HK$101.8m; trade payables HK$87.0m; net current assets HK$110.9m; current ratio 2.0x; quick ratio 1.4x; gearing 5.3% [IR2026].
Cash flow
Sources: [SA] for OCF and capex (secondary aggregator of filed statements); buybacks nil per [AR2025] and prior reports' statements of no repurchases (FY2025, FY2024 confirmed; earlier years per absence of share count changes).
Interim cash flow: H1 2026 operating cash outflow HK$13.1m vs inflow HK$5.9m in H1 2025; capex HK$1.5m; net decrease in cash HK$18.4m [IR2026].
Commentary. FY2025's HK$28.4m OCF despite a HK$15.2m loss was flattered by working-capital release (inventory −HK$11.4m) and heavier receivables factoring: factored and derecognised receivables rose from HK$39.4m (Dec 2024) to HK$102.4m (Dec 2025), then fell to HK$44.5m (Jun 2026) [IR2025], [IR2026]. The H1 2026 operating outflow partly reflects that unwind. Underlying cash generation is therefore weaker than headline FY2025 FCF implies.
Ratios
Sources: [AR2025], [AR2024s] (FY2023 current/quick/gearing from comparatives), derived. ROIC uses operating profit taxed at 16.5% where positive; where negative, operating loss is used untaxed. Net debt/EBITDA for FY2025 is mechanically extreme because EBITDA is near zero; it is not economically meaningful. Receivable days are understated by factoring.
Trend, inflection and driver commentary
FY2021 (recovery): Revenue rebounded 22.7% post-COVID; still loss-making due to cost base. Management also explored NEV diversification (placing and MOU) [AR2021], [ANN-JUN21], [ANN-JUL21].
FY2022 (peak profitability post-IPO): GM 16.3%, profit HK$9.2m supported by HK$13.1m other income [AR2022], [AR2025].
FY2023 (volume shock): Revenue −15.5% on European weakness; profit held positive only via HK$24.1m other income [AR2023], [AR2025].
FY2024 (margin collapse): Volume recovered (+15.3%) but GM fell to 9.8%; net loss HK$21.6m [AR2024s].
FY2025 (partial repair): Volume growth plus cost saving lifted GP 32.7%; loss narrowed to HK$15.2m but FX turned negative as RMB appreciated [AR2025].
H1 2026 (relapse): Revenue −9.5% on ASP pressure; GM 10.5%; selling costs +41% (advertising/promotion); loss widened to HK$12.1m [IR2026].
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Segment Margins & Growth (%)
| Segment | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Eyewear products revenue (HKD Mn) | 434.7 | 465.4 | 393.3 | 453.6 | 500.3 |
Eyewear products YoY growth (%) | 22.7 | 7.1 | -15.5 | 15.3 | 10.3 |
Eyewear products pre-tax profit (HKD Mn) | -1.6 | 10.7 | 2.2 | -21.4 | -13.7 |
Eyewear products pre-tax margin (%, derived) | -0.4 | 2.3 | 0.6 | -4.7 | -2.7 |
Share of group revenue (%) | 100 | 100 | 100 | 100 | 100 |
Results by Segment and Segment Margins & Growth (%)
| Metric | H1 2024 | H2 2024 | H1 2025 | H2 2025 | H1 2026 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 197.4 | 256.2 | 242.5 | 257.7 | 219.6 |
Gross profit (HKD Mn) | 17.8 | 26.9 | 31.2 | 28.1 | 23.0 |
Gross margin (%) | 9.0 | 10.5 | 12.9 | 10.9 | 10.5 |
Net profit (HKD Mn) | -12.3 | -9.4 | -4.7 | -10.4 | -12.1 |
Group Entities
| Entity | Location | Role (as disclosed/inferred) | Source |
|---|---|---|---|
Kelfred Holdings Limited | Cayman Islands | Listed investment holding company | [IR2026] |
Huaqing Glasses (Shenzhen) Company Limited | Shenzhen, PRC | Manufacturing; High and New Technology Enterprise (15% tax rate) | [IR2026] note 7 |
Jiangxi Huaqing Glasses Co., Limited | Jiangxi, PRC | Manufacturing (self-owned base); R&D super-deduction claimant | [IR2026] note 7 |
Yingtan Euro-Asia Enterprise Limited | Yingtan, Jiangxi, PRC | Small and Low-profit Enterprise (20% preferential rate) | [IR2026] note 7 |
東宇科技有限公司 (Dongyu Technology Limited) | Hong Kong (directly wholly-owned per 2021 announcement) | Vehicle used for 2021 NEV MOU | [ANN-JUL21] |
Thailand operating subsidiary | Thailand | Third production base; name not disclosed in documents reviewed. Non-controlling interests first appeared in FY2025 (−HK$47k), consistent with a non-wholly-owned new subsidiary (analyst inference, unconfirmed) | [AR2025], [IR2026] |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 434.7 | 465.4 | 393.3 | 453.6 | 500.3 |
Cost of sales (HKD Mn) | 366.3 | 389.4 | 336.3 | 408.9 | 440.9 |
Gross profit (HKD Mn) | 68.4 | 76.0 | 57.0 | 44.7 | 59.3 |
Other income gains and losses (HKD Mn) | 5.3 | 13.1 | 24.1 | 12.8 | 6.4 |
Selling and distribution expenses (HKD Mn) | 13.8 | 14.6 | 17.1 | 14.8 | 16.9 |
Administrative and other opex (HKD Mn) | 60.9 | 63.6 | 60.2 | 62.0 | 60.5 |
Operating profit (HKD Mn) | -1.1 | 11.4 | 3.9 | -19.5 | -11.1 |
D&A (HKD Mn, aggregator) | 14.2 | 9.7 | 10.4 | 12.2 | 11.4 |
EBITDA (HKD Mn, derived) | 13.1 | 21.1 | 14.2 | -7.3 | 0.3 |
Finance costs (HKD Mn) | 0.5 | 0.7 | 1.7 | 2.0 | 2.6 |
Pre-tax profit (HKD Mn) | -1.6 | 10.7 | 2.2 | -21.4 | -13.7 |
Income tax (HKD Mn) | 0.6 | 1.5 | 0.8 | 0.2 | 1.4 |
Net profit (HKD Mn) | -2.1 | 9.2 | 1.4 | -21.6 | -15.2 |
Net profit attributable to owners (HKD Mn) | -2.1 | 9.2 | 1.4 | -21.6 | -15.1 |
EPS basic and diluted (HK cents) | -0.43 | 1.84 | 0.28 | -4.33 | -3.02 |
Dividend per share (HK cents) | — | — | — | 0 | 0 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 15.7 | 16.3 | 14.5 | 9.8 | 11.9 |
Operating margin (%) | -0.2 | 2.4 | 1.0 | -4.3 | -2.2 |
EBITDA margin (%, derived) | 3.0 | 4.5 | 3.6 | -1.6 | 0.1 |
Net margin (%) | -0.5 | 2.0 | 0.4 | -4.8 | -3.0 |
Revenue growth (%) | 22.7 | 7.1 | -15.5 | 15.3 | 10.3 |
Opex to revenue (%, derived) | 17.2 | 16.8 | 19.7 | 16.9 | 15.5 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 268.1 | 251.9 | 264.0 | 282.9 | 282.8 |
Total liabilities (HKD Mn) | 81.8 | 65.3 | 80.8 | 126.5 | 134.4 |
Total equity (HKD Mn) | 186.3 | 186.6 | 183.2 | 156.4 | 148.5 |
Cash and bank balances (HKD Mn) | — | — | 20.3 | 27.8 | 48.0 |
Total debt incl. leases (HKD Mn) | — | — | 15.2 | 12.6 | 8.5 |
Short-term debt (HKD Mn) | — | — | — | 3.4 | 3.5 |
Long-term debt (HKD Mn) | — | — | — | 9.2 | 5.0 |
Net debt (HKD Mn, negative = net cash) | — | — | -5.1 | -15.3 | -39.5 |
Goodwill and intangibles (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Net current assets (HKD Mn) | — | — | — | 121.9 | 117.9 |
Inventories (HKD Mn) | — | — | — | 85.8 | 74.7 |
Trade receivables (HKD Mn) | — | — | — | 116.8 | 113.4 |
Trade payables (HKD Mn) | — | — | — | 91.2 | 98.8 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (HKD Mn) | -21.9 | 19.3 | -4.6 | 17.5 | 28.4 |
Capex (HKD Mn) | 5.1 | 4.7 | 15.7 | 5.0 | 2.4 |
Free cash flow (HKD Mn, derived) | -27.0 | 14.6 | -20.3 | 12.5 | 25.9 |
Dividends paid (HKD Mn) | — | — | — | 0 | 0 |
Share buybacks (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%, net profit / closing equity, derived) | -1.1 | 4.9 | 0.8 | -13.8 | -10.2 |
ROA (%, net profit / closing assets, derived) | -0.8 | 3.6 | 0.5 | -7.6 | -5.4 |
ROIC (%, derived approx: NOPAT / (equity + debt − cash)) | — | — | 1.8 | -14.4 | -11.0 |
Current ratio (x) | — | — | 3.1 | 2.0 | 1.9 |
Quick ratio (x) | — | — | 2.0 | 1.3 | 1.3 |
Debt to equity (%) | — | — | 8.3 | 8.0 | 5.7 |
Net debt to EBITDA (x, derived) | — | — | -0.4 | — | -131.7 |
Interest coverage (x, EBIT / finance cost, derived) | -2.1 | 15.4 | 2.3 | -9.8 | -4.2 |
Asset turnover (x, derived) | 1.62 | 1.85 | 1.49 | 1.60 | 1.77 |
Inventory days (derived) | — | — | — | 76.6 | 61.8 |
Receivable days (derived) | — | — | — | 94.0 | 82.7 |
Payable days (derived) | — | — | — | 81.4 | 81.8 |
Cash conversion cycle (days, derived) | — | — | — | 89.2 | 62.7 |
Revenue by Region
| Region | H1 2024 | H1 2025 | H1 2026 |
|---|---|---|---|
Italy (HKD Mn) | 87.8 | 84.5 | 70.8 |
United Kingdom (HKD Mn) | 52.2 | 70.9 | 55.4 |
Hong Kong (HKD Mn) | 36.8 | 65.7 | 54.4 |
United States (HKD Mn) | 6.9 | 11.2 | 7.9 |
Japan (HKD Mn) | 2.8 | 2.9 | 1.8 |
All other destinations (HKD Mn, derived residual) | 10.9 | 7.3 | 29.3 |
Total (HKD Mn) | 197.4 | 242.5 | 219.6 |
Geographic Revenue
| Region | H1 2025 YoY growth (%) | H1 2026 YoY growth (%) | H1 2026 share of revenue (%) |
|---|---|---|---|
Italy | -3.7 | -16.2 | 32.2 |
United Kingdom | 35.9 | -21.8 | 25.2 |
Hong Kong | 78.7 | -17.2 | 24.8 |
United States | 62.2 | -29.3 | 3.6 |
Japan | 3.1 | -38.1 | 0.8 |
All other (derived) | -33.4 | 302.4 | 13.3 |
Geographic Revenue (H1 2025 (HKD Mn)–H1 2026 (HKD Mn))
| Country | H1 2025 (HKD Mn) | H1 2026 (HKD Mn) | Comment |
|---|---|---|---|
Spain | 0.0 | 14.9 | New material market; 6.8% of H1 2026 revenue |
PRC | 1.8 | 5.7 | Domestic sales tripled |
Philippines | 0.0 | 2.8 | New |
Sweden | 0.1 | 2.6 | New |
Others | 5.3 | 3.3 | Residual as reported |
Locations
| Location | 31 Dec 2024 | 30 Jun 2025 | 31 Dec 2025 | 30 Jun 2026 |
|---|---|---|---|---|
Hong Kong (HKD Mn) | 2.6 | 1.7 | 1.1 | 1.4 |
PRC (HKD Mn) | 39.9 | 35.0 | 32.3 | 30.2 |
Thailand (HKD Mn) | 0.0 | 0.0 | 1.4 | 1.1 |
Share Price History
| Date | Price (HKD) | Implied market cap (HKD Mn) | Source |
|---|---|---|---|
16 Jul 2019 (IPO) | 1.00 | 500 | [IPO2019] |
4 Jun 2021 (pre-placing close) | 1.55 | 775 | [ANN-JUN21] |
~May 2025 | ~0.17 | ~86 | Market data summary (TipRanks) |
~Aug 2025 | ~0.19 | ~94.5 | Market data summary (TipRanks) |
23 Apr 2026 | 0.30 | 150 | etnet quote |
31 Jul 2026 | 0.33 | 165 | [SA] |
Return measure (approximate, to 31 Jul 2026) | Value (%) | — | — |
~1-year (from ~HK$0.19, Aug 2025) | 74 | — | — |
~5-year (from HK$1.55, Jun 2021) | -79 | — | — |
Since IPO (HK$1.00) | -67 | — | — |
Valuation Multiples
| Multiple | Kelfred | Arts Optical (1120.HK) | Sun Hing (0125.HK) |
|---|---|---|---|
Market cap (HKD Mn) | 165 | 348 | 78 |
P/E (x) | n/m (TTM loss ≈ HK$22.5m) | ~16.8 | n/m (loss) |
EV/EBITDA (x) | n/m (TTM EBITDA ≈ −HK$9.4m) | — | n/m |
EV/Sales (x) | ~0.30 (EV ≈ HK$143m pre post-period loans; TTM revenue HK$477.3m) | ~0.26 (P/S basis) | ~0.09 (P/S basis) |
P/B (x) | ~1.16 (NAV HK$141.7m) | — | — |
Analyst Conclusions
Management guidance
Qualitative only: the environment remains challenging into H2 2026 and 2027 due to trade frictions and geopolitics; continued cost saving, supply-chain optimisation, innovative designs, Thailand ramp-up and diversification exploration [IR2026]. No numerical guidance.
Consensus growth expectations
None available.
Bull case
-
Thailand unlocks tariff-advantaged orders: with US deliveries already down 29% in H1 2026, a non-China base could recapture US and tariff-sensitive European programmes and support ASPs [IR2026].
-
Operating leverage on recovery: admin costs flat at ~HK$60m for five years; a return to FY2022's 16% gross margin on FY2025 revenue would add ~HK$21m gross profit and restore operating profit (derived) [AR2025].
-
Corporate-control optionality: a fragmented new register (59.19% held by three new holders) and a net-cash, ungeared listed vehicle trading near 1.2x book create scope for capital injection, asset injection or strategic redirection [IR2026].
Bear case
-
Structural margin erosion: ASP declines and RMB strength compressed GM to 10.5% in H1 2026, eliminating most of the FY2025 repair; peers face the same pressure [IR2026], [PEER].
-
Cash runway is finite: cash fell to HK$29.9m with an H1 2026 operating outflow of HK$13.1m, and seasonal borrowing needs have risen (RMB18.95m July 2026 loan) [IR2026].
-
Governance discontinuity: the operating management (Kwok brothers) no longer has an ownership stake, while new holders' intentions are undisclosed — raising the risk of management departures, customer disruption, or a non-eyewear pivot with dilution [ANN-29JUL26], [IR2026].
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing | Why it matters |
|---|---|---|
| Thailand base start of production | H2 2026 | Tests the diversification thesis |
| FY2026 annual results | ~Mar 2027 | H2 margin trajectory; FX; full-year country mix |
| Board/management changes following ownership transfer | Any time | Signals new holders' strategy; Kwok brothers' continuity |
| Any capital raising under general mandate | Any time | Dilution vs fresh capital |
| Substantial-shareholder moves near 30% Takeovers Code threshold (Hu Xing at 29.59%) | Any time | Potential general offer dynamics |
| Customer A/B/C order trends | Interim/annual | Concentration risk |
| RMB/HKD exchange rate | Continuous | Direct gross-margin and FX-line impact |
| Factoring utilisation and seasonal borrowings | Interim/annual | Liquidity quality |
Analyst verdict
Kelfred Holdings is, at its core, a sub-scale Chinese eyewear ODM/OEM supplier whose economics have deteriorated materially since its 2019 listing. Revenue has grown only ~3.6% a year since FY2021 and reached a record HK$500.3m in FY2025, yet gross margin has fallen from 16.3% (FY2022) to 10.5% (H1 2026), and the group has lost money in every reported period since the start of FY2024. Management's levers — cost cutting, design-fee monetisation, new markets such as Spain, and a Thailand production base — are sensible but incremental, and none has yet offset ASP deflation, RMB appreciation and soft European demand. The balance sheet remains a genuine positive: no financial debt at period-ends, net cash, and an owned Jiangxi facility that can be pledged. But cash dropped by over a third in H1 2026, and working capital leans on factoring and short-term secured loans.
The more consequential development is outside the P&L. Between April and July 2026 the founding Kwok family sold its entire 54.19% stake; the register is now led by Ms. Hu Xing (29.59%), executive director Liu Zhen (19.60%) and Ms. Tam Man Yee (10.00%), and the company states there is no controlling shareholder. The share price has roughly doubled from mid-2025 lows, and the stock now trades at ~1.2x book and ~0.3x sales despite losses — a valuation that only makes sense if investors are paying for control optionality. The investment case has therefore shifted from "eyewear turnaround" to "what will new owners do with the listed vehicle", with outcomes ranging from capital injection and diversification to dilution and management attrition.
Verdict: fundamentally weak, governance in transition, and speculative. Absent clarity on the new shareholders' strategy and evidence that Thailand restores margins, the risk/reward is unfavourable for fundamentals-driven investors.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed / tenure | Age | Background & education | Source |
|---|---|---|---|---|---|
Mr. Kwok Kwan Fai (Joe Kwok) | Chairman, Executive Director; Chair of Nomination Committee | Joined group Apr 1998 (27+ yrs) | 52 | B.Bus (Accounting), Monash University (1995); audit trainee K.L. Wong & Co.; Manulife unit manager | [AR2025] |
Mr. Kwok Kwan Yu (Ken Kwok) | CEO, Executive Director | Joined Dec 1999 (26+ yrs) | 48 | Secondary education, Hong Kong; controls DEM FACTORY SRL (51%) | [AR2025], [IR2026] |
Mr. Liu Zhen | Executive Director | 15 May 2026 | — | MD of Prestige Wealth Management (since Dec 2022); deputy finance director, Airport City Development (2022); deputy GM, Hong Kong Airlines (2017–2022); holds 19.60% | [ANN-15MAY26], [IR2026] |
Mr. Kwok Mau Kwan | Non-Executive Director; co-founder | Since 1986 (39+ yrs) | 82 | Honorary chairman, Jiangxi Yingtan Optical Industry Association; CPPCC Yujiang District committee member | [AR2025] |
Ms. Chan Yin Wah (Mrs. Kwok) | Non-Executive Director; Nomination Committee (from 25 Mar 2026) | Joined Aug 1987 (38+ yrs) | 73 | Secondary education, Hong Kong | [AR2025], [IR2026] |
Mr. Chu Kin Ming | INED; Audit Committee Chair | 22 Jun 2019 | 45 | HKICPA; EMBA CUHK (2022); BA Accountancy PolyU; multiple HK listed-company INED/CoSec roles | [AR2025] |
Mr. Leung Ka Tin | INED; Remuneration Committee Chair | 1 Jan 2025 | 72 | Banking/treasury/corporate finance (FPB Asia, Nedcor Asia, Delta Asia); INED of Gilston Group (2011.HK) and Star Group Asia (1560.HK, from Apr 2026) | [AR2025], [IR2026] |
Mr. Hon Ming Sang | INED; Risk Management Committee Chair | 1 Jul 2026 | — | CFO and company secretary, China Gas Industry Investment Holdings; ex-international audit firm | [ANN-30JUN26] |
“—” = not publicly disclosed.
Executive Leadership Team
| Name | Role | Since | Background |
|---|---|---|---|
Mr. Choi Chun Wai | CFO and Company Secretary | Joined 2021; appointed 1 Jan 2025 | HKICPA; BBA CUHK (2010); MCG PolyU (2020); KPMG 2010–2017 |
Directors' Remuneration
| Component (HKD K) | H1 2024 | H1 2025 | H1 2026 |
|---|---|---|---|
Fees | 270 | 270 | 293 |
Salaries and allowances | 3,718 | 2,101 | 1,917 |
Benefits in kind | 68 | 53 | 44 |
Retirement contributions | 18 | 18 | 18 |
Total | 4,074 | 2,442 | 2,272 |
Shareholding Trend
| Holder | 30 Jun 2025 | 31 Dec 2025 | 30 Jun 2026 | Post 24 Jul 2026 | Source |
|---|---|---|---|---|---|
Conquer Holding Ltd (Kwok family: Joe 49%, Ken 49%, Mrs. Kwok 2%) | 54.19% | 54.19% | 29.59% | 0.00% | [IR2025], [AR2025], [IR2026], [ANN-29JUL26] |
Ms. Hu Xing (independent third party) | — | — | — | 29.59% | [IR2026] |
Mr. Liu Zhen (Executive Director) | — | — | 19.60% | 19.60% | [IR2026] |
Ms. Tam Man Yee | — | — | 10.00% | 10.00% | [IR2026] |
Mr. Kwok Hon Yim | 5.04% | 5.45% | not listed (<5%) | not listed | [IR2025], [AR2025], [IR2026] |
Mr. Leung Ka Tin (INED) | 1.00% | 1.00% | not listed | not listed | [IR2025], [AR2025], [IR2026] |
Competitive Landscape
Key Competitors
| Competitor | Listing | Segment overlap | Latest revenue | Relative positioning vs Kelfred | Source |
|---|---|---|---|---|---|
Arts Optical International | 1120.HK | ODM frames & sunglasses; also lenses, distribution, own brands | HK$1,333.9m (FY2025) | ~2.7x Kelfred's revenue; diversified into lenses and Asia; factories in China, Vietnam, lens plant in Malaysia; profitable | [PEER] |
Sun Hing Vision Group | 0125.HK | ODM eyewear + brand licensing/distribution; Italy largest market | HK$891.0m (FY to Mar 2026) | ~1.8x Kelfred's revenue; similar margin squeeze; loss-making; bases outside China | [PEER] |
EssilorLuxottica | EL.PA | Vertically integrated frames/lenses/retail; also a customer/benchmark for the industry | — | Global leader; sets price and design trends | — |
Safilo Group | SFL.MI | Eyewear design/manufacture/licensing; also outsources to Asian ODMs | — | Mid-tier global; potential customer and competitor | — |
Marcolin | Private (Italy) | Licensed eyewear; sources from Asian manufacturers | — | Brand owner/licensee | — |
De Rigo | Private (Italy) | Manufacturing, licensing, retail | — | European integrated player | — |
Kering Eyewear | Part of Kering | In-house luxury eyewear | — | Insourcing luxury competes with ODM outsourcing | — |
Charmant Group | Private (Japan) | Titanium frame manufacturing | — | Higher-end technical frames | — |
Mainland Chinese ODM clusters (Shenzhen Henggang, Xiamen, Wenzhou, Danyang, Yingtan) | Mostly private | Volume frame/sunglass ODM | — | Key price competition driving ASP declines | [IR2026] context |
Southeast Asian manufacturers (Vietnam/Thailand-based) | Various | Tariff-advantaged production | — | Competitive threat Kelfred is responding to via Thailand | Analyst assessment |
“—” = not publicly disclosed.
Peer Comparison FY2025
| Metric | Kelfred FY2025 | Arts Optical FY2025 | Sun Hing FY Mar-2026 |
|---|---|---|---|
Revenue (HKD Mn) | 500.3 | 1,333.9 | 891.0 |
Revenue growth (%) | 10.3 | 4.0 | 7.6 |
Gross margin (%) | 11.9 | 31.4 | 10.9 |
Net margin (%) | -3.0 | 1.6 | -5.2 |
Employees (approx.) | 752 | 3,400 | 3,000 |



